ArticleFrontiers in artificial intelligence2026
Lung cancer classification and severity estimation using vision transformer-IPCNN with enhanced U-Net segmentation.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The death rate due to lung cancer is increasing because of late detection. Several automated lung cancer diagnostic techniques based on Machine Learning (ML) and Deep Learning (DL) have been developed for early detection. However, existing methods have limitations, including higher false-positive rates, lower sensitivity, and greater time consumption, which can affect early lung cancer diagnosis. Methods: To address these limitations, the Lung Cancer Classification and Severity Estimation-Improved Parallel Convolutional Neural Network-Vision Transformer (LCCSE-IPCNN-ViT) model is proposed. The framework consists of preprocessing, segmentation, classification, and severity estimation phases. First, the input images are preprocessed using the Improved Wiener Filtering (IWF) technique. The preprocessed images are then segmented using the Modified TransUNet (MTransUNet) model. Finally, the segmented images are classified and their severity is estimated using the IPCNN-ViT model, which combines the Improved Parallel Convolutional Neural Network (IPCNN) and Vision Transformer (ViT). Results: The proposed LCCSE-IPCNN-ViT model achieved an accuracy of 97.3%, sensitivity of 97.8%, specificity of 96.8%, precision of 96.8%, F-measure of 97.3%, and ROC-AUC of 98.5%. Discussion: The experimental results demonstrate that the proposed LCCSE-IPCNN-ViT model provides accurate and efficient lung cancer classification and severity estimation, indicating its potential for supporting early lung cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.